ReCAP: Detection of Potentially Avoidable Harm in Oncology From Patient Medical Records

Author:

Lipitz-Snyderman Allison1,Weingart Saul N.1,Anderson Christopher1,Epstein Andrew S.1,Killen Aileen1,Classen David1,Sima Camelia S.1,Fortier Elizabeth1,Atoria Coral L.1,Pfister David1,Lipitz-Snyderman Allison2,Weingart Saul N.2,Anderson Christopher2,Epstein Andrew S.2,Killen Aileen2,Classen David2,Sima Camelia S.2,Fortier Elizabeth2,Atoria Coral L.2,Pfister David2

Affiliation:

1. Memorial Sloan Kettering Cancer Center; Columbia University Medical Center; AIG, New York, NY; Tufts Medical Center, Boston, MA; Pascal Metrics, Washington, DC; University of Utah School of Medicine, Salt Lake City, UT; and Genentech, San Francisco, CA

2. Memorial Sloan Kettering Cancer Center; Columbia University Medical Center; AIG, New York, NY; Tufts Medical Center, Boston, MA; Pascal Metrics, Washington, DC; University of Utah School of Medicine, Salt Lake City, UT; and Genentech, San Francisco, CA.

Abstract

QUESTION ASKED: Although medical record–based measurement of adverse events (AEs) associated with cancer care is desirable, condition-specific triggers in oncology care are needed. We sought to develop a screening tool to facilitate efficient detection of AEs across settings of cancer care via medical record review. We hope to use this tool to understand the frequency, spectrum, and preventability of AEs with the goal of helping improve the quality and safety of cancer care. SUMMARY ANSWER: We developed a cancer-specific screening tool to help identify candidate preventable AEs that occur during cancer care from patients’ medical records. Our oncology screening tool consists of 76 triggers—readily identifiable findings to screen for possible AEs that occur during cancer care ( Table 1 ). METHODS: We sought to develop a screening tool to facilitate the detection of AEs across settings of cancer care via medical record review. We obtained structured and unstructured input from clinical experts to develop our tool, using a modified Delphi process. BIAS, CONFOUNDING FACTOR(S), DRAWBACKS: Our oncology tool requires further evaluation in order to understand its usefulness for population-based assessments of AEs in oncology and quality improvement. REAL-LIFE IMPLICATIONS: Information obtained from structured record reviews using an oncology trigger tool could help to prioritize quality improvement activities, identify high-risk groups, and generate cancer-focused quality measures. Ultimately, the goals of this work are to prevent AEs and allow timely, automated identification of these events so that clinicians can intervene promptly to improve patient outcomes. [Table: see text]

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3